Asia Pacific Artificial Cornea and Corneal Implant Market

Market Introduction

An artificial cornea implant is a surgery to eliminate all or part of a damaged cornea and replace it with healthy donor tissue. But, currently, there shortage of cornea donors worldwide, and eye and tissue banking is also not carrying in many countries. Meanwhile, there is always the possibility that the human eye will reject the transplantation, which can cause infection or lack of vision. Cornea Implant is usually performed under certain conditions such as keratoconus, degenerative disease, or other. The artificial cornea tissue can be made up of polymer plastic such as silica material. Artificial cornea implant is of two types, i.e., synthetic cornea implant and biosynthetic cornea implant.

Asia Pacific Artificial Cornea and Corneal Implant Strategic Insights

Strategic insights for the Asia Pacific Artificial Cornea and Corneal Implant provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

Asia Pacific Artificial Cornea and Corneal Implant Report Scope

Asia Pacific Artificial Cornea and Corneal Implant Regional Insights

The geographic scope of the Asia Pacific Artificial Cornea and Corneal Implant refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The Asia Pacific artificial cornea and corneal implant market is expected to reach US$ 163.61 million by 2028 from an estimated value of US$ 94.71 million in 2021; it is likely to grow at a CAGR of 8.1% from 2021-2028. The key factors that are driving the growth of market are rising prevalence of eye diseases that causes corneal blindness, significantly rising elderly population are factors propelling the artificial cornea and corneal implant market. However, the expensive ophthalmology surgeries and devices may hamper the growth of the Europe artificial cornea and corneal implant market in the forecast period.

According to American Academy of Ophthalmology 2021, there is a high demand for corneal donors around the world as ~10 million people need corneal transplants. However, the number of transplant recipients greatly exceeds the availability of corneal tissues. In densely populated counties, such as India, patients with blind cornea wait for corneal transplants for more than 6 months. According to National Center for Biotechnology Information, ~6.8 million people across the country have poor vision in one eye, and ~1 million people have both their eyes with poor vision, caused by corneal diseases. In 2019, corneal blindness affected ~120,000 people India, and by the end of 2020, it is estimated to have 10.6 million cases of unilateral corneal blindness. The country needs ~250,000 corneas each year; however, the total number of corneas donated each year is ~25,000. Thus, the shortage of corneal donors, in contrast with the high prevalence of corneal blindness, is expected to provide high growth opportunities for corneal implant manufacturers. A team of researchers from the Pohang University of Science and Technology, and the Kyungpook National University School of Medicine in South Korea collaborated to 3D print artificial corneas using tissue-based bio-inks; the research has been published in "Biofabrication", in 2018. Since the 3D printed corneas are made from corneal tissue materials, they are biocompatible, and the corneal microenvironment is reproduced through 3D cell printing technology to make them transparent, like human cornea. The 3D printed artificial corneas also help overcome the complications related to synthetic cornea implanted in patients with cataracts and other ocular complications. Furthermore, one of the key advantages of 3D printing is that collagen can be deposited in layers, which allows for the simulation of the composition of collagen fibers in the natural corneal matrix. Thus, upon their successful commercialization for clinical usage, the 3D printed biocorneas are likely to emerge as a significant trend in the artificial cornea and corneal implant market. 

Corneal transplantation suffered an early setback due to a reduction in elective procedures as resources were diverted to handling COVID-19-infected patients. The possibility of COVID-19 ocular involvement has consequences for corneal donation as well. The risk of transmitting the virus via corneal transplantation to recipients led to its suspension until adequate polymerase chain reaction (PCR) testing could be performed to exclude donor infection in some centers. Furthermore, the corneal donor supply chain has been impacted by worldwide travel restrictions. This is especially important in many regions of Asia, where demand for eye transplants is primarily dependent on imported donors due to a lack of local eye banks. This could spur research into lamellar keratoplasty, the development of artificial corneas, or cell treatment to improve donor utility. In the post-pandemic environment, evaluation of corneal disorders may see a paradigm change toward telemedicine or artificial intelligence to satisfy these unmet requirements across Asia.

Key Market Segments

The Asia Pacific artificial cornea and corneal implant market based on type is segmented into human cornea, and artificial cornea. In 2021, the human cornea segment is likely to hold the largest share of the market, however artificial cornea is expected to grow at the highest CAGR during the forecast period.

The Asia Pacific artificial cornea and corneal implant market based on the transplant type is segmented into penetrating keratoplasty, endothelial keratoplasty, and others. In 2021, the penetrating keratoplasty segment is likely to hold the largest share of the market however, endothelial keratoplasty is expected to grow at the fastest rate during the coming years.

The Asia Pacific artificial cornea and corneal implant market by disease indication, is segmented into Fuchs’ Dystrophy, keratoconus, fungal keratitis, others. The Fuchs’ Dystrophy segment is likely to hold the largest share of the market in 2021, however the fungal keratitis segment is anticipated to register the highest CAGR of the market during the forecast period.

The Asia Pacific artificial cornea and corneal implant market by end user, is segmented into hospitals, specialty clinics and ASCs and others. The specialty clinics and ASCs segment are likely to hold the largest share of the market in 2021 is anticipated to register the highest CAGR of the market during the forecast period.

Major Sources and Companies Listed

A few of the primary and secondary sources associated with this report on the Asia Pacific artificial cornea and corneal implant market are the Singapore Eye Research Institute (SERI), Japanese Ministry of Health, Labor and Welfare (MHLW), Korea Centers for Disease Control and Prevention (KNHANES) and Australian Bureau of Statistics (ABS).

Reasons to buy the report

• Determine prospective investment areas based on a detailed trend analysis of Asia Pacific artificial cornea and corneal implant market over the next years.
• Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
• Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
• Identify the major channels driving the Asia Pacific artificial cornea and corneal implant market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
• Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Asia Pacific artificial cornea and corneal implant market.

ASIA PACIFIC ARTIFICIAL CORNEA AND CORNEAL IMPLANT MARKET SEGMENTATION

By

Type

• Human Cornea
• Artificial Cornea

By

Transplant Type

• Penetrating Keratoplasty
• Endothelial Keratoplasty
• Others

By Disease Indication

• Fuchs’ Dystrophy
• Keratoconus
• Fungal Keratitis
• Others

By End User

• Hospitals
• Specialty Clinics and ASCs
• Others

By Country

• China
• Japan
• India
• Australia
• Southeast Asia
• South Korea
• Rest of Asia Pacific

Company Profiles

• AJL OPHTHALMIC S.A
• Aurolab
• CORNEA BIOSCIENCES, INC
• EyeYon Medical
• Florida Lions Eye Bank